News | February 24, 2024
Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
The company is strongly committed to enhancing customer satisfaction and catering to the discerning needs of renowned pharmaceutical companies
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
Equipped with most advanced Distributed Control System (DCS) automation technology, the facility has been set up with an investment of Rs. 200 crore
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Lupin enters into BTA with Lupin Manufacturing Solutions
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Subscribe To Our Newsletter & Stay Updated
